Vaccinex Inc. (NASDAQ: VCNX) is -25.77% lower on its value in year-to-date trading and has touched a low of $3.22 and a high of $12.23 in the current 52-week trading range. The VCNX stock was last observed hovering at around $3.49 in the last trading session, with the day’s gains setting it 0.11% off its average median price target of $22.00 for the next 12 months. It is also 83.64% off the consensus price target high of $22.00 offered by 3 analysts, but current levels are 82.0% higher than the price target low of $20.00 for the same period.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Currently trading at $3.60, the stock is 0.74% and -2.88% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.22 million and changing 3.15% at the moment leaves the stock -27.90% off its SMA200. VCNX registered -29.55% loss for a year compared to 6-month loss of -28.22%. The firm has a 50-day simple moving average (SMA 50) of $3.6709 and a 200-day simple moving average (SMA200) of $4.6455.
The stock witnessed a -2.70% gain in the last 1 month and extending the period to 3 months gives it a -11.33%, and is 2.86% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.45% over the week and 5.97% over the month.
Vaccinex Inc. (VCNX) has around 45 employees, a market worth around $58.72M and $0.40M in sales. Distance from 52-week low is 11.80% and -70.56% from its 52-week high. The company has generated returns on investments over the last 12 months (122.20%).
Vaccinex Inc. (VCNX) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Vaccinex Inc. (VCNX) is a “Buy”. 3 analysts offering their recommendations for the stock, where 0 rate it as a Hold and 0 think it is a “Overweight”. 3 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Vaccinex Inc. is expected to release its quarterly report on 08/12/2020 and quarterly earnings per share for the current quarter are estimated at -$0.51 with sales reaching $100k over the same period.The EPS is expected to grow by 3.80% this year, but quarterly earnings will post -42.60% year-over-year. Quarterly sales are estimated to grow 300.00% in year-over-year returns.
Vaccinex Inc. (VCNX) Top Institutional Holders
18 institutions hold shares in Vaccinex Inc. (VCNX), with 3.89M shares held by insiders accounting for 23.39% while institutional investors hold 77.51% of the company’s shares. The shares outstanding are 16.00M, and float is at 11.95M with Short Float at 1.74%. Institutions hold 59.38% of the Float.
The top institutional shareholder in the company is MSD Partners, L.P. with over 1.16 million shares valued at $4.65 million. The investor’s holdings represent 6.98% of the VCNX Shares outstanding. As of Mar 30, 2020, the second largest holder is Vanguard Group, Inc. (The) with 0.14 million shares valued at $0.55 million to account for 0.83% of the shares outstanding. The other top investors are Millennium Management LLC which holds 44494.0 shares representing 0.27% and valued at over $0.18 million, while Oppenheimer & Company Inc. holds 0.17% of the shares totaling 27651.0 with a market value of $0.11 million.
Vaccinex Inc. (VCNX) Insider Activity
A total of 10 insider transactions have happened at Vaccinex Inc. (VCNX) in the last six months, with sales accounting for 0 and purchases happening 10 times.